ImmunityBio, Inc. IBRX
- ANKTIVA — Non-Muscle Invasive Bladder Cancer NDA Submitted
- ANKTIVA — Non-Small Cell Lung Cancer Phase 2
IL-15 (1 companies · 2 programs)
Companies with an active program directed at IL-15.
Companies with an active program directed at IL-15.